Literature DB >> 16697813

Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis.

Michael W Kattan1, Vincenzo Ficarra, Walter Artibani, Sergio Cosciani Cunico, Andrea Fandella, Guido Martignoni, Giacomo Novara, Tommaso Prayer Galetti, Filiberto Zattoni.   

Abstract

PURPOSE: We created the first nomograms to predict cancer specific survival probabilities of patients with squamous cell carcinoma of the penis, clustering prognostic information from the most commonly used clinical and pathological variables.
MATERIALS AND METHODS: We retrospectively collected clinical and pathological data from 175 patients who had undergone surgery for squamous cell carcinoma of the penis from 1980 to 2002 at 11 urological centers in northeastern Italy. A logistic regression model was used to construct the nomogram.
RESULTS: At a median followup of 24 months, 101 patients (57.7%) were alive and disease-free while 74 (42.3%) died of penile cancer. According to multivariate analyses, 2 models predictive of cancer specific survival probability were generated. The first model was based on the pathological findings of the primary tumor after penectomy and on the clinical stage of groin lymph nodes, while the second model included the pathological data of the primary tumor and groin lymph nodes. The concordance index was 0.728 for the first model and 0.747 for the second. Calibration appeared to be good in both models.
CONCLUSIONS: In this article we propose 2 models to predict the 5-year cancer specific survival probabilities of patients with squamous cell carcinoma of the penis. Both models showed good discriminating power and calibration in predicting patient 5-year cancer specific survival. These nomograms could improve the quality of prognostic data provided to patients and support physicians in planning treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16697813     DOI: 10.1016/S0022-5347(06)00313-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Video Endoscopic Inguinal Lymphadenectomy (VEIL): Minimally Invasive Radical Inguinal Lymphadenectomy Technique.

Authors:  Rawal Sudhir; Raghunath S Krishnappa; Samir Khanna; R Sekon; Rakesh Koul
Journal:  Indian J Surg Oncol       Date:  2012-07-04

2.  Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study.

Authors:  Daniele Minardi; Guendalina Lucarini; Alessandra Filosa; Antonio Zizzi; Oriana Simonetti; Anna Maria Offidani; Gianluca d'Anzeo; Roberto Di Primio; Rodolfo Montironi; Giovanni Muzzonigro
Journal:  Cell Oncol (Dordr)       Date:  2012-09-13       Impact factor: 6.730

Review 3.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

4.  Contemporary management of penile cancer: greater than 15 year MSKCC experience.

Authors:  Kelvin A Moses; Andrew Winer; John P Sfakianos; Stephen A Poon; Matthew Kent; Melanie Bernstein; Paul Russo; Guido Dalbagni
Journal:  Can J Urol       Date:  2014-04       Impact factor: 1.344

5.  What next? Managing lymph nodes in men with penile cancer.

Authors:  Michael Leveridge; D Robert Siemens; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

Review 6.  How accurate are present risk group assignment tools in penile cancer?

Authors:  Vincenzo Ficarra; G Novara; R Boscolo-Berto; W Artibani; M W Kattan
Journal:  World J Urol       Date:  2008-06-17       Impact factor: 4.226

Review 7.  The role of pathologic prognostic factors in squamous cell carcinoma of the penis.

Authors:  Antonio L Cubilla
Journal:  World J Urol       Date:  2008-09-03       Impact factor: 4.226

8.  DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma.

Authors:  Oliver J Kayes; Marco Loddo; Nimish Patel; Pranav Patel; Suks Minhas; Gareth Ambler; Alex Freeman; Alex Wollenschlaeger; David J Ralph; Kai Stoeber; Gareth H Williams
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

Review 9.  Understanding genomics and the immune environment of penile cancer to improve therapy.

Authors:  Ahmet Murat Aydin; Jad Chahoud; Jacob J Adashek; Mounsif Azizi; Anthony Magliocco; Jeffrey S Ross; Andrea Necchi; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2020-08-18       Impact factor: 14.432

Review 10.  Epigenetic mechanisms in penile carcinoma.

Authors:  Hellen Kuasne; Fabio Albuquerque Marchi; Silvia Regina Rogatto; Ilce Mara de Syllos Cólus
Journal:  Int J Mol Sci       Date:  2013-05-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.